Jiayan Mao
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Surfaces, Coatings and Films top 10%
- Surface Modification and Superhydrophobicity
Papers in
-
- RNA modifications and cancer 7
- Circular RNAs in diseases 4
- S100 Proteins and Annexins 2
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 8
- Co-authors
- Xiaoxiao Zheng (9 shared papers)Wei Chen (10 shared papers)Shufen Zhang (7 shared papers)Ying Wu (3 shared papers)Kequn Chai (6 shared papers)Shangzhi Xie (7 shared papers)Wei Chen (5 shared papers)Liqiang Hu (6 shared papers)
- Journals
- Cell Death Discovery (3 papers)Cell Death and Disease (3 papers)Clinical & Translational Oncology (1 paper)Journal of Cellular Biochemistry (1 paper)Human Cell (1 paper)
- Partner nations
- ChinaUnited StatesTunisia
In The Last Decade
Jiayan Mao
28 papers receiving 599 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 308
- Surfaces, Coatings and Films 41
- Molecular Biology 387
- Epidemiology 99
- Oncology 74
Countries citing papers authored by Jiayan Mao
This map shows the geographic impact of Jiayan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayan Mao more than expected).
Fields of papers citing papers by Jiayan Mao
This network shows the impact of papers produced by Jiayan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayan Mao. The network helps show where Jiayan Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiayan Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 88 | |
| 2 | 2020 | 74 | |
| 3 | 2021 | 61 | |
| 4 | 2021 | 52 | |
| 5 | 2019 | 42 | |
| 6 | 2020 | 40 | |
| 7 | 2020 | 38 | |
| 8 | 2020 | 36 | |
| 9 | 2022 | 31 | |
| 10 | 2019 | 26 | |
| 11 | GC7 blocks epithelial-mesenchymal transition and reverses hypoxia-induced chemotherapy resistance in hepatocellular carcinoma cells. | 2017 | 20 |
| 12 | 2018 | 12 | |
| 13 | 2023 | 10 | |
| 14 | 2022 | 8 | |
| 15 | 2017 | 8 | |
| 16 | 2020 | 8 | |
| 17 | 2017 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2024 | 5 | |
| 20 | WZ4003 sensitizes non-small cell lung cancer cells to gefitinib via inhibition of ARK5 and epithelial-to-mesenchymal transition. | 2020 | 5 |
About Jiayan Mao
Jiayan Mao is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Epidemiology and Pathology and Forensic Medicine, having authored 29 papers that have together received 601 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers), RNA modifications and cancer (7 papers), Circular RNAs in diseases (4 papers), Autophagy in Disease and Therapy (4 papers), Electrospun Nanofibers in Biomedical Applications (2 papers), S100 Proteins and Annexins (2 papers) and Surface Modification and Superhydrophobicity (2 papers). The work is most often cited by research in Cancer Research (308 citations), Surfaces, Coatings and Films (41 citations), Molecular Biology (387 citations), Epidemiology (99 citations) and Oncology (74 citations). Jiayan Mao has collaborated with scholars based in China, United States and Tunisia. Frequent co-authors include Xiaoxiao Zheng, Wei Chen, Shufen Zhang, Ying Wu, Kequn Chai, Shangzhi Xie, Wei Chen, Liqiang Hu, Xuemei Lu and Xuning Shen. Their work appears in journals such as Cell Death Discovery, Cell Death and Disease, Clinical & Translational Oncology, Journal of Cellular Biochemistry and Human Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.